跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Can AI Discover New Drugs? A High-Level Overview

1Why Drug Discovery Is Hard, and Where AI Fits2How AI Learns From Molecules and Proteins3Finding and Validating a Biological Target4Designing Molecules: Generative AI and Virtual Screening5From Hit to Lead: Optimizing Properties With AI6What AI Still Cannot Do7Judging the Claims: Real Successes, Failures, and Open Questions
From Hit to Lead: Optimizing Properties With AI

Predicting What the Body Will Do to a Molecule

2 / 4
The structure on the left is the only input. From it, separate models each answer a different question: how much crosses the gut wall, where it distributes in the body, how fast the liver breaks it down, how quickly it is cleared, and whether it is toxic or blocks the heart channel. Each model was trained on compounds whose behavior was actually measured in the lab, so it has learned which structural features tend to go with which outcomes. The result is a panel of estimates. Notice that no single number decides anything — the panel is read together, and it lets chemists set aside likely failures before spending weeks synthesizing them.
0:00 / 0:00

Before a compound is synthesized, AI models can estimate what the body will do to it. These predictions are grouped under the label ADMET: absorption, distribution, metabolism, excretion, and toxicity.

Absorption asks how much of an oral dose crosses from the gut into the bloodstream. Distribution asks where the compound goes once in circulation — whether it reaches the tissue of interest or is largely bound to blood proteins. Metabolism asks how quickly liver enzymes chemically modify and deactivate it. Excretion asks how fast the body removes it. Toxicity asks whether the compound or its breakdown products harm cells, and whether it interferes with proteins such as the hERG ion channel, whose blockage is associated with dangerous heart-rhythm effects.

Each of these is predicted from the same input the model already uses for binding: the molecular structure. A trained model maps structural features — polarity, size, the presence of particular chemical groups — onto measured outcomes from thousands of compounds whose ADMET behavior was determined experimentally. The output is a panel of estimates attached to the structure, letting chemists discard compounds that are likely to fail on absorption or safety before spending weeks making them.

上一页2 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion